• About
  • Advertise
  • Privacy & Policy
  • Contact
Sunday, November 22, 2026
  • Login
  • Register
thehopper.news
  • Home
    • Home
    • About
    • Editorial Standards
    • Methodology & Sources
  • Briefings
    • Weekly
  • Analysis
  • Regions
    • Africa
    • Americas
    • Asia-Pacific
    • Europe & NATO
    • Middle East & North Africa
    • Russia & Eurasia
  • Themes
    • Energy & Reources
    • Intelligence & Security
    • Economics & Sanctions
    • Foreign Relations & Diplomacy
    • Cyber & Disinformation
  • Video
  • Aggregated
    • RT
    • Opinion
    • News
    • Geopolitics
    • Politics
    • Business
    • World
No Result
View All Result
thehopper.news
No Result
View All Result
Home Aggregated RT

Russia can beat EU’s new superbug threat – top scientist

by Admin
November 22, 2026
in RT, World
0
Russia can beat EU’s new superbug threat – top scientist
27
SHARES
108
VIEWS
Share on FacebookShare on Twitter

Published: November 22, 2026 12:59 pm
Author: RT

Fluorothiazinone has already helped save hundreds of patients, including those with severe postoperative infections, Alexander Gintsburg says

Russia has a drug capable of tackling antibiotic-resistant strains of a bacterium that can cause potentially fatal pneumonia and bloodstream infections and is spreading through European hospitals, a top Russian scientist has said.

Speaking to RIA Novosti on Saturday, Alexander Gintsburg, the scientific director of Russia’s Gamaleya Research Center, weighed in on warnings from the European Center for Disease Prevention and Control (ECDC) over the alarming spread of the Klebsiella pneumoniae bacterium. The watchdog reported on Wednesday that bloodstream infections caused by strains resistant to powerful antibiotics known as carbapenems have increased by 72% in the EU since 2019.

The World Health Organization (WHO) echoed this, saying it found resistance to key antibiotics in at least half of the samples of Klebsiella pneumoniae in around one in two countries in Europe.

Read more

RT
US hospitals and nursing homes are breeding grounds for deadly superbugs – CDC

The bacterium normally lives harmlessly in the human gut but can cause pneumonia, urinary tract infections, and potentially deadly bloodstream infections, particularly among hospitalized patients. Some strains even resist last-resort antibiotics, although the EU has several approved drugs that can treat certain resistant infections.

Gintsburg stated that Russia has already rolled out a drug – Fluorothiazinone – that can overcome the threat, noting that it has already helped save hundreds of patients and is being used to treat severe postoperative complications approaching sepsis. He added that the Russian Health Ministry is reviewing documents seeking approval for broader use for antibiotic-resistant infections.

Read more

RT
Scientists create viruses with AI

Russia first registered Fluorothiazinone in April 2024 for complex urinary tract infections in combination with cefepime. Unlike conventional antibiotics, it aims to disarm bacteria rather than killing them directly, disrupting mechanisms that help them cause disease.

The drug has undergone several clinical trials. A 2024 randomized trial involving 357 patients found that Fluorothiazinone combined with cefepime achieved a 75.6% cure rate, compared with 50.8% for cefepime and placebo. Researchers also reported no serious adverse events during the study.

Another trial involving 280 patients published in October found effectiveness comparable to a conventional antibiotic against recurrent bladder infections.

The Gamaleya Research Center developed Sputnik V, which was registered in August 2020 as the world’s first Covid-19 vaccine, months ahead of its Western competitors. Gintsburg reportedly tested it on himself and members of his family.

Although the early rollout raised concerns because large-scale trials had not yet been completed, subsequent research published in The Lancet found the vaccine to be 91.6% effective against symptomatic Covid-19.

Despite these results and the nationwide rollout in Russia, Sputnik V never received EU-wide or US authorization amid geopolitical tensions. The EU stalled the process, citing incomplete clinical and manufacturing data, and the vaccine was never submitted to the US Food and Drug Administration. Nevertheless, Hungary and Slovakia broke ranks with the rest of the EU and procured Sputnik V independently during the height of the pandemic.

Full Article

Tags: Russia Today
Share11Tweet7
Previous Post

Russian Orthodox cleric urges GTA VI players to repent

Next Post

The EU must negotiate with Russia directly – ‘party of peace’ MEP

Admin

Admin

Next Post
The EU must negotiate with Russia directly – ‘party of peace’ MEP

The EU must negotiate with Russia directly – ‘party of peace’ MEP

  • Trending
  • Comments
  • Latest

Paul Mason instigated GCHQ targeting of The Grayzone’s Kit Klarenberg, leaks reveal

March 23, 2026

Trump White House plagiarized Iran war manifesto from Israel-aligned think tank

March 21, 2026

Drugs, sexual blackmail: shocking confession letter exposes Israel’s Red Crescent spy ring

March 26, 2026
Iranian drone intercepted over Dubai UAE March 2026 Operation Epic Fury

The Hopper Daily Brief — March 3, 2026 — Iran Escalates Against Gulf Targets

2
Smoke rising over Manama Bahrain near U.S. Fifth Fleet headquarters following Iranian missile strike February 2026

Bahrain’s Shia Majority Threatens the U.S. Navy’s Most Critical Gulf Command Node

2
Oil tankers idle in Persian Gulf and Trump demands Iran unconditional surrender — week of March 1–7, 2026 Hopper Weekly Brief

The Hopper Weekly Brief — Week 10, March 1-7, 2026

2
Russian Orthodox cleric urges GTA VI players to repent

Russian Orthodox cleric urges GTA VI players to repent

November 22, 2026
Merz putting Ukraine before Germany – MP

Merz putting Ukraine before Germany – MP

November 22, 2026
Slovakia refuses to fund EU ‘gifts’ to Kiev – Fico

Slovakia refuses to fund EU ‘gifts’ to Kiev – Fico

November 22, 2026
thehopper.news

Copyright © 2023 The Hopper New

Navigate Site

  • About
  • Advertise
  • Privacy & Policy
  • Contact

Follow Us

Welcome Back!

Login to your account below

Forgotten Password? Sign Up

Create New Account!

Fill the forms bellow to register

*By registering into our website, you agree to the Terms & Conditions and Privacy Policy.
All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist

No Result
View All Result
  • Home
    • Home
    • About
    • Editorial Standards
    • Methodology & Sources
  • Briefings
    • Weekly
  • Analysis
  • Regions
    • Africa
    • Americas
    • Asia-Pacific
    • Europe & NATO
    • Middle East & North Africa
    • Russia & Eurasia
  • Themes
    • Energy & Reources
    • Intelligence & Security
    • Economics & Sanctions
    • Foreign Relations & Diplomacy
    • Cyber & Disinformation
  • Video
  • Aggregated
    • RT
    • Opinion
    • News
    • Geopolitics
    • Politics
    • Business
    • World

Copyright © 2023 The Hopper New

This website uses cookies. By continuing to use this website you are giving consent to cookies being used. Visit our Privacy and Cookie Policy.